The objective of the study was to assess the effects of B-group vitamins and antioxidants vitamin C and E on lipid profiles and homocysteine levels in type 2 diabetic patients. In a block randomized, double-blind, placebo controlled clinical trial, 110 type 2 diabetic patients were assigned into five groups and received one of the following daily supplement for 2 months: group B: 10mg riboflavin, 10mg pyridoxine, 200µg cobalamin and 1000µg folic acid (n=23), group BE: same as group B and 100mg vitamin E(n=21), group BC: same as group B and 200mg vitamin C(n=22), group BCE: same as group BC and 100mg vitamin E(n=22), group P: Placebo(n=22). Fasting blood and urine samples were collected; body weight, height, waist circumference, hip circumference, dietary intake were also recorded at the beginning and at the end of 2 months trial and analyzed for cholesterol, triglyceride, HDL-c, LDL-c, apolipoproteins (apo) A1, vitamin E, folic acid, vitamin B12, vitamin C, and homocysteine.